Australia’s active vaccine safety system

Shingrix®

Vaccine safety data

On 1 November 2023, Shingrix® replaced Zostavax® on the National Immunisation Program schedule for the prevention of shingles and post-herpetic neuralgia. 

Shingrix® has been available to purchase privately for use in Australia since 2021 and has been shown to be safe and effective both in Australia and overseas. 

To support the rollout of Shingrix® to a broader population, AusVaxSafety is conducting enhanced active surveillance of Shingrix® across Australia to provide reassurance that the short-term safety profile of the vaccine is consistent with previous surveillance activities.

Surveillance data are gathered by AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following Shingrix® vaccination. Data on this page are updated monthly.

 


Latest Shingrix® vaccine safety data

Click on the tiles below to view AusVaxSafety Shingrix® safety data for specific population groups.

Shingrix® safety data – all participants

View the latest safety data here.
Vaccine safety data

News & events

All news & events

AusVaxSafety receives funding
from the Australian Government

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

Copyright © 2022 AusVaxSafety. All rights reserved

vaccine

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.